Hydrocortisone acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for hydrocortisone acetate and what is the scope of freedom to operate?
Hydrocortisone acetate
is the generic ingredient in nineteen branded drugs marketed by Mylan Speciality Lp, Fougera Pharms, Able, Cenci, Imperium, Parke Davis, Purepac Pharm, Sebela Ireland Ltd, Taro, Pharmacia And Upjohn, Pfizer, Bel Mar, Epic Pharma Llc, Watson Labs, Merck, Ingram Pharm, Fera Pharms, Colgate, X Gen Pharms, Monarch Pharms, Genus, and Ferndale Labs, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.There are fourteen drug master file entries for hydrocortisone acetate. Two suppliers are listed for this compound.
Summary for hydrocortisone acetate
US Patents: | 0 |
Tradenames: | 19 |
Applicants: | 22 |
NDAs: | 40 |
Drug Master File Entries: | 14 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 19 |
Patent Applications: | 6,486 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for hydrocortisone acetate |
What excipients (inactive ingredients) are in hydrocortisone acetate? | hydrocortisone acetate excipients list |
DailyMed Link: | hydrocortisone acetate at DailyMed |
Recent Clinical Trials for hydrocortisone acetate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Medical Center Groningen | Early Phase 1 |
National Institutes of Health Clinical Center (CC) | Phase 2 |
University of Texas Southwestern Medical Center | Phase 2 |
Pharmacology for hydrocortisone acetate
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for hydrocortisone acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | NEO-CORTEF | hydrocortisone acetate; neomycin sulfate | SUSPENSION/DROPS;OPHTHALMIC | 060612-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | CORTEF ACETATE | hydrocortisone acetate | OINTMENT;TOPICAL | 008917-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ferndale Labs | PRAMOSONE | hydrocortisone acetate; pramoxine hydrochloride | LOTION;TOPICAL | 083213-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.